Rapamycin Pretreatment Attenuates High Glucose-induced Alteration of Synaptic Transmission in Hippocampal Dentate Gyrus Neurons
Authors:
- 16 March 2022
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 490, 182-192
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81771979, 32070988)
This publication has 25 references indexed in Scilit:
- Reduction of the Cholesterol Sensor SCAP in the Brains of Mice Causes Impaired Synaptic Transmission and Altered Cognitive FunctionPLOS Biology, 2013
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Diabetes Depresses Synaptic Transmission in Sympathetic Ganglia by Inactivating nAChRs through a Conserved Intracellular Cysteine ResidueNeuron, 2010
- Increased Tau Phosphorylation and Cleavage in Mouse Models of Type 1 and Type 2 DiabetesEndocrinology, 2009
- Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron lossNature Neuroscience, 2009
- Glucose increases synaptic transmission from vagal afferent central nerve terminals via modulation of 5-HT3 receptorsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and FunctionThe Journal of Neuroscience, 2008
- Interaction of brain somatostatin receptors with the PDZ domains of PSD‐95FEBS Letters, 2007
- PSD-95 is required for activity-driven synapse stabilizationProceedings of the National Academy of Sciences, 2007
- The rapamycin-sensitive signal transduction pathway as a target for cancer therapyOncogene, 2000